Spots Global Cancer Trial Database for primary hepatocellular carcinoma

Every month we try and update this database with for primary hepatocellular carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC	NCT02018757	Carcinoma, Hepa...	TACE containing... TACE containing...	18 Years - 75 Years	First Hospital of China Medical University
A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma	NCT01171651	Carcinoma, Hepa...	JX-594 followed...	18 Years -	SillaJen, Inc.
Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients	NCT02956772	Primary Hepatoc...	TACE Arsenic trioxid...	18 Years - 80 Years	Hunan Provincial People's Hospital
Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients	NCT02956772	Primary Hepatoc...	TACE Arsenic trioxid...	18 Years - 80 Years	Hunan Provincial People's Hospital
Clinical Study of MAK Immune Cells in the Treatment of PHC	NCT05242757	Primary Hepatoc...	Mixed-activated...	18 Years -	Zhongnan Hospital
Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media	NCT01563484	Primary Hepatoc...		18 Years - 75 Years	Southeast University, China
Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC	NCT02018757	Carcinoma, Hepa...	TACE containing... TACE containing...	18 Years - 75 Years	First Hospital of China Medical University
Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma	NCT05087459	Thrombocytopeni...	Avatrombopag	18 Years -	Shanghai Zhongshan Hospital
Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients	NCT02956772	Primary Hepatoc...	TACE Arsenic trioxid...	18 Years - 80 Years	Hunan Provincial People's Hospital
Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003	NCT00405873	Hepatocellular ...	AMT2003	18 Years - 79 Years	Auron Healthcare GmbH
Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma	NCT03614546	Primary Hepatoc...	SBRT IMRT Hepatectomy TACE	18 Years - 80 Years	The Third Xiangya Hospital of Central South University
Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy	NCT01828762	Primary Hepatoc...	DC-TC+GM-CSF	18 Years - 80 Years	Cellular Biomedicine Group Ltd.
Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media	NCT01563484	Primary Hepatoc...		18 Years - 75 Years	Southeast University, China
Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma	NCT00966251	Primary Hepatoc...	CT-011	18 Years -	CureTech Ltd
Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma	NCT03614546	Primary Hepatoc...	SBRT IMRT Hepatectomy TACE	18 Years - 80 Years	The Third Xiangya Hospital of Central South University
Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients	NCT02956772	Primary Hepatoc...	TACE Arsenic trioxid...	18 Years - 80 Years	Hunan Provincial People's Hospital
Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy	NCT01828762	Primary Hepatoc...	DC-TC+GM-CSF	18 Years - 80 Years	Cellular Biomedicine Group Ltd.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: